Orally active benzamide inhibitors of p38 mitogen-activated protein kinase

被引：0

作者：

Boman, E. ^{[1
]}

Chang, A. ^{[1
]}

Ceide, S. Conde ^{[1
]}

Dahl, R. ^{[1
]}

Dalesandro, D. ^{[1
]}

Delaet, N. G. J. ^{[1
]}

Erb, E. ^{[1
]}

Ernst, J. ^{[1
]}

Gibbs, A. ^{[1
]}

Kahl, J. ^{[1
]}

Kessler, L. ^{[1
]}

Larson, C. J. ^{[1
]}

Lundstrom, J. ^{[1
]}

Miller, S. ^{[1
]}

Montalban, A. G. ^{[1
]}

Nakanishi, H. ^{[1
]}

Roberts, E. ^{[1
]}

Saiah, E. ^{[1
]}

Sullivan, R. ^{[1
]}

Wang, Z. ^{[1
]}

机构：

[1] Kemia Inc, San Diego, CA 92121 USA

来源：

INFLAMMATION RESEARCH | 2006年 / 55卷

关键词：

D O I：

暂无

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

引用

页码：S111 / S111

页数：1

共 50 条

[21] NMR Spectroscopic Investigations of the Activated p38α Mitogen-Activated Protein Kinase
Nielsen, Gerd
Schwalbe, Harald
CHEMBIOCHEM, 2011, 12 (17) : 2599 - 2607
[22] Dehydroeplandrosterone negatively regulates the p38 mitogen-activated protein kinase pathway by a novel mitogen-activated protein kinase phosphatase
Ashida, K
Goto, K
Zhao, Y
Okabe, T
Yanase, T
Takayanagi, R
Nomura, M
Nawata, H
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2005, 1728 (1-2): : 84 - 94
[23] Role of p38 mitogen-activated protein kinase in thrombus formation
Sakurai, K
Matsuo, Y
Sudo, T
Takuwa, Y
Kimura, S
Kasuya, Y
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 : 88P - 88P
[24] P38 mitogen-activated protein kinase (MAPK) in rheumatoid arthritis
Westra, J.
Limburg, P. C.
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2006, 6 (08) : 867 - 874
[25] Multiple activation mechanisms of p38α mitogen-activated protein kinase
Kang, Young Jun
Seit-Nebi, Alim
Davis, Roger J.
Han, Jiahuai
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (36) : 26225 - 26234
[26] p38 Mitogen-Activated Protein Kinase Inhibitors: A Review on Pharmacophore Mapping and QSAR Studies
Gangwal, Rahul P.
Bhadauriya, Anuseema
Damre, Mangesh V.
Dhoke, Gaurao V.
Sangamwar, Abhay T.
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2013, 13 (09) : 1015 - 1035
[27] Pyridinylquinoxalines and Pyridinylpyridopyrazines as Lead Compounds for Novel p38α Mitogen-Activated Protein Kinase Inhibitors
Koch, Pierre
Jahns, Hartmut
Schattel, Verena
Goettert, Marcia
Laufer, Stefan
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (03) : 1128 - 1137
[28] P38 mitogen-activated protein kinase regulates the differentiation of oligodendrocytes
Haines, J. D.
Fragoso, G.
Mushynski, W. E.
Almazan, G.
JOURNAL OF NEUROCHEMISTRY, 2007, 102 : 261 - 261
[29] P38 MITOGEN-ACTIVATED PROTEIN KINASE AND PARKINSON'S DISEASE
He, Jianying
Zhong, Wenwen
Zhang, Ming
Zhang, Rongping
Hu, Weiyan
TRANSLATIONAL NEUROSCIENCE, 2018, 9 (01) : 147 - 153
[30] Role of p38 mitogen-activated protein kinase in thrombus formation
Sakurai, K
Matsuo, Y
Sudo, T
Takuwa, Y
Kimura, S
Kasuya, Y
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2004, 24 (04) : 283 - 296

← 1 2 3 4 5 →